Gilead Science

Gilead soars 11% after reporting positive news on potential coronavirus treatment (GILD) Shares of Gilead surged as much as 11% in early trading Wednesday after the company said a leading coronavirus treatment succeeded in a critical trial. The positive news led the S&P 500 as much as 2.4% higher in premarket trading in New York.  Gilead’s remdesivir, an antiviral drug,…...

This content is for Monthly Subscription , Yearly Subscription , and 6 month Subscription members only.
Log In Register

Comments are closed.